Bayer Schering links with Chinese hospital for women's health research
This article was originally published in Scrip
Bayer Schering Pharma (BSP) has signed an agreement with a major government hospital in China to conduct joint research in various areas with an initial focus on women's health.
You may also be interested in...
Partners say they are encouraged by new overall response data from early trials for the two drugs together in kidney and liver cancer, presented to ASCO.
Focused on precision medicine for renal disease, Chinook gets Aduro’s Nasdaq listing and starting capital of $200m. During a wave of modest-sized M&A deals, Tetra finds buyer, Tetraphase gets competing bids.
Takeda is confident about the promise of its first-in-class molecule for higher-risk myelodysplastic syndromes after positive Phase II data.